Key result
Serum albumin <3.8 g/dL linked to ~400% higher 10-year mortality vs >4.1 g/dL in hemodialysis patients.
Why the study?
It remains unclear which parameters among serum albumin, CRP, and CA-IMT are more reliable predictors of long-term mortality in hemodialysis patients.
Does low serum albumin predict 10-year mortality better than CRP and carotid intima-medial thickness in hemodialysis patients?
Cohort (n=168)
Does low serum albumin predict 10-year mortality better than CRP and carotid intima-medial thickness in hemodialysis patients?
Odds Ratio: 5.04 (95% CI 1.3–19.6)
p-value: p=0.02
Serum albumin is a superior predictor of 10-year mortality compared to CRP and carotid intima-media thickness in hemodialysis patients.
No takes yet. Share an insight, caveat, or question.
Serum albumin may aid long-term mortality risk assessment in HD patients; leaves open whether CRP or CA-IMT add independent value.
Kato et al. (2010) conducted a cohort in Hemodialysis (n=168). Serum albumin <3.8 g/dL vs. Serum albumin >4.1 g/dL was evaluated on Total mortality (OR 5.04, 95% CI 1.30-19.60, p=0.02). In hemodialysis patients, serum albumin <3.8 g/dL was associated with a significantly higher risk of 10-year total mortality compared with albumin >4.1 g/dL (OR 5.04; 95% CI 1.30-19.60; P=0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: